Optical Coherence Tomography of Plaque Erosion : JACC Focus Seminar Part 2/3
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved..
Plaque erosion, a distinct histopathological and clinical entity, accounts for over 30% of acute coronary syndromes (ACS). Optical coherence tomography allows in vivo diagnosis of plaque erosion. Local flow perturbation with activation of Toll-like receptor 2 and CD8+ T cells and subsequent desquamation of endothelium and neutrophil extracellular trap formation contribute to mechanisms of plaque erosion. Compared with ACS patients with plaque rupture, those with plaque erosion are younger, have fewer traditional cardiovascular risk factors, have lower plaque burden, and are more likely to present with non-ST-segment elevation ACS. Early evidence suggests that in patients with ACS caused by plaque erosion, antithrombotic therapy without stenting may be a safe and effective option. Future randomized trials are needed to validate these findings. Clinical studies to develop noninvasive point-of-care biomarkers that distinguish plaque rupture from erosion, and to test novel therapies that target molecular pathways involved in plaque erosion are needed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Journal of the American College of Cardiology - 78(2021), 12 vom: 21. Sept., Seite 1266-1274 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kolte, Dhaval [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute coronary syndromes |
|---|
| Anmerkungen: |
Date Completed 17.12.2021 Date Revised 17.12.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jacc.2021.07.030 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330729985 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330729985 | ||
| 003 | DE-627 | ||
| 005 | 20231225211918.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jacc.2021.07.030 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1102.xml |
| 035 | |a (DE-627)NLM330729985 | ||
| 035 | |a (NLM)34531028 | ||
| 035 | |a (PII)S0735-1097(21)05713-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kolte, Dhaval |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Optical Coherence Tomography of Plaque Erosion |b JACC Focus Seminar Part 2/3 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2021 | ||
| 500 | |a Date Revised 17.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Plaque erosion, a distinct histopathological and clinical entity, accounts for over 30% of acute coronary syndromes (ACS). Optical coherence tomography allows in vivo diagnosis of plaque erosion. Local flow perturbation with activation of Toll-like receptor 2 and CD8+ T cells and subsequent desquamation of endothelium and neutrophil extracellular trap formation contribute to mechanisms of plaque erosion. Compared with ACS patients with plaque rupture, those with plaque erosion are younger, have fewer traditional cardiovascular risk factors, have lower plaque burden, and are more likely to present with non-ST-segment elevation ACS. Early evidence suggests that in patients with ACS caused by plaque erosion, antithrombotic therapy without stenting may be a safe and effective option. Future randomized trials are needed to validate these findings. Clinical studies to develop noninvasive point-of-care biomarkers that distinguish plaque rupture from erosion, and to test novel therapies that target molecular pathways involved in plaque erosion are needed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a acute coronary syndromes | |
| 650 | 4 | |a coronary thrombosis | |
| 650 | 4 | |a erosion | |
| 650 | 4 | |a optical coherence tomography | |
| 650 | 4 | |a plaque | |
| 700 | 1 | |a Yonetsu, Taishi |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Jong Chul |e verfasserin |4 aut | |
| 700 | 1 | |a Libby, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Fuster, Valentin |e verfasserin |4 aut | |
| 700 | 1 | |a Jang, Ik-Kyung |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American College of Cardiology |d 1987 |g 78(2021), 12 vom: 21. Sept., Seite 1266-1274 |w (DE-627)NLM012608602 |x 1558-3597 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2021 |g number:12 |g day:21 |g month:09 |g pages:1266-1274 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jacc.2021.07.030 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2021 |e 12 |b 21 |c 09 |h 1266-1274 | ||